secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001493152-22-035782
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences receives Nasdaq delisting notice for MVLS non-compliance
----------------------------------------------------------------------------

- Nasdaq notified Ensysce on Dec 14, 2022, that it failed to regain compliance with $35M minimum value of listed securities (MVLS) requirement.
- Company had until Dec 13, 2022 to meet MVLS rule; failed to do so, triggering delisting process.
- Ensysce will timely request a hearing before Nasdaq Hearings Panel to stay delisting.
- Panel may grant extension up to June 12, 2023, but no assurance of success or continued listing.
- Common stock (ENSC) and warrants (ENSCW) trading subject to potential suspension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315222035782/0001493152-22-035782-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315222035782/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-035782

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer